Supply of API 20 E Strips for Microbiological Testing

The contract is for the supply of API 20 E Strips used in microbiological testing to identify Enterobacteriaceae and other Gram-negative bacteria within FDA laboratory operations. These strips are critical reagents for accurate bacterial identification and are essential for ensuring the reliability of diagnostic results in regulatory and public health contexts. The contract is structured as a subcontract under the Department of Health and Human Services, specifically managed by the FDA Office of Acquisition and Grant Services, and is classified under NAICS code 325412, indicating it pertains to the manufacturing of diagnostic reagents. The solicitation was posted on May 7, 2026, with a response deadline of May 15, 2026, at 7:00 PM, indicating a tight procurement timeline to ensure timely availability of test materials. The place of performance and point of contact details are not specified, but performance is expected to support FDA laboratory functions regardless of location. No set-aside designation is indicated, meaning the contract is open to all eligible contractors without preference for small business, minority-owned, or other specialized categories. The procurement is conducted through the SAM.gov platform, and vendors must comply with the technical specifications for API 20 E Strips to meet FDA’s standards for microbiological testing accuracy and consistency.